Return
Bronchiolitis
DOI:10.1016/S0140-6736(22)01016-9.png)
Abstract
En 中文
Viral bronchiolitis is the most common cause of admission to hospital for infants in high-income countries. Respiratory syncytial virus accounts for 60-80% of bronchiolitis presentations. Bronchiolitis is diagnosed clinically without the need for viral testing. Management recommendations, based predominantly on high-quality evidence, advise clinicians to support hydration and oxygenation only. Evidence suggests no benefit with use of glucocorticoids or bronchodilators, with further evidence required to support use of hypertonic saline in bronchiolitis. Evidence is scarce in the intensive care unit. Evidence suggests use of high-flow therapy in bronchiolitis is limited to rescue therapy after failure of standard subnasal oxygen only in infants who are hypoxic and does not decrease rates of intensive care unit admission or intubation. Despite systematic reviews and international clinical practice guidelines promoting supportive rather than interventional therapy, universal de-implementation of interventional care in bronchiolitis has not occurred and remains a major challenge.
Keywords:
RESPIRATORY SYNCYTIAL VIRUS
LENGTH-OF-STAY
ACUTE VIRAL BRONCHIOLITIS
OXYGEN-SATURATION TARGETS
HOSPITALIZED INFANTS
YOUNG-CHILDREN
PALIVIZUMAB PROPHYLAXIS
EMERGENCY-DEPARTMENT
HYPERTONIC SALINE
CONTROLLED-TRIAL
Journal
IF:
88.5
Papers:
5.4W
Citations:
39.6W
Organization
Cited Papers
Practice Variation in Acute Bronchiolitis: A Pediatric Emergency Research Networks Study
PEDIATRICS
IF6.4
Isotonic Versus Hypotonic Maintenance IV Fluids in Hospitalized Children: A Meta-Analysis
PEDIATRICS
IF6.4
Clinical Practice Guideline: The Diagnosis, Management, and Prevention of Bronchiolitis
PEDIATRICS
IF6.4
Association of Diagnostic Criteria With Urinary Tract Infection Prevalence in Bronchiolitis A Systematic Review and Meta-analysis
JAMA PEDIATRICS
IF18

